TLR3+ Cancers

TLR3+ cancer

TLR3 agonists have a therapeutic potential in multiple TLR3+ cancer indications.

TLR3+ Cancers Tollys
Logo Tollys

Tollys

Triggering & installing efficient anti-tumor immunity

Office

60 avenue Rockefeller
69008 Lyon, FRANCE

Contact us